This inventor holds 3 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignees: Abbvie Deutschland Gmbh and Co Kg, Abbvie Inc.. Active years: 2014-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2014-2018
Title: Christina M Thompson: Innovator in Pharmaceutical Modulation
Introduction
Christina M Thompson is a prominent inventor based in Evanston, IL, known for her significant contributions to the field of pharmaceutical sciences. With a total of three patents to her name, she has made strides in the development of modulators for 5-HT receptors, which play a crucial role in various biological processes.
Latest Patents
Her latest patents focus on aryl- and heteroaryl-fused compounds, specifically decahydropyrroloazepine and its derivatives. These patents detail compositions that include these compounds, processes for their synthesis, and methods for treating various disease conditions. The innovative nature of her work lies in the potential applications of these compounds in therapeutic settings, showcasing her commitment to advancing medical science.
Career Highlights
Throughout her career, Christina has worked with notable companies such as AbbVie Deutschland GmbH & Co. KG and AbbVie Inc. Her experience in these organizations has allowed her to collaborate with leading experts in the field, further enhancing her expertise and contributions to pharmaceutical innovation.
Collaborations
Some of her notable coworkers include Irini Akritopoulou-Zanze and Wilfried Martin Braje, who have played a role in her professional journey. Their collaborative efforts have contributed to the success of her projects and the advancement of their shared goals in the pharmaceutical industry.
Conclusion
Christina M Thompson's work exemplifies the impact of innovative thinking in the pharmaceutical sector. Her patents and collaborations reflect her dedication to improving health outcomes through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile